{
     "PMID": "8866962",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19970115",
     "LR": "20131121",
     "IS": "0091-3057 (Print) 0091-3057 (Linking)",
     "VI": "53",
     "IP": "3",
     "DP": "1996 Mar",
     "TI": "Intraseptal microinjection of beta-funaltrexamine blocked a microwave-induced decrease of hippocampal cholinergic activity in the rat.",
     "PG": "613-6",
     "AB": "Acute (45 min) exposure to pulsed (2 microseconds pulse width, 500 pulses per second) 2450-MHz microwaves at a power density of 1 mW/cm2 (whole body specific absorption rate 0.6 W/kg) microwaves caused a decrease in cholinergic activity in the hippocampus of the rat as measured by the sodium-dependent high-affinity choline uptake. Microinjection of beta-funaltrexamine (1 microgram) into the septum before microwave exposure blocked this effect. These data indicate that mu-opioid receptors in the septum mediate a microwave-induced decrease in cholinergic activity in the hippocampus and support our hypothesis that microwaves at a whole body SAR of 0.6 W/kg can activate endogenous opioids in the brain.",
     "FAU": [
          "Lai, H",
          "Carino, M A",
          "Horita, A",
          "Guy, A W"
     ],
     "AU": [
          "Lai H",
          "Carino MA",
          "Horita A",
          "Guy AW"
     ],
     "AD": "Department of Pharmacology, University of Washington, Seattle 98195, USA. hlai@u.washington.edu",
     "LA": [
          "eng"
     ],
     "GR": [
          "ES-03712/ES/NIEHS NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, U.S. Gov't, P.H.S."
     ],
     "PL": "United States",
     "TA": "Pharmacol Biochem Behav",
     "JT": "Pharmacology, biochemistry, and behavior",
     "JID": "0367050",
     "RN": [
          "0 (Narcotic Antagonists)",
          "5S6W795CQM (Naltrexone)",
          "72782-05-9 (beta-funaltrexamine)",
          "N91BDP6H0X (Choline)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Choline/metabolism",
          "Cholinergic Fibers/*drug effects",
          "Hippocampus/*drug effects",
          "Male",
          "Microinjections",
          "Naltrexone/*analogs & derivatives/pharmacology",
          "Narcotic Antagonists/*pharmacology",
          "Rats",
          "Rats, Sprague-Dawley"
     ],
     "EDAT": "1996/03/01 00:00",
     "MHDA": "1996/03/01 00:01",
     "CRDT": [
          "1996/03/01 00:00"
     ],
     "PHST": [
          "1996/03/01 00:00 [pubmed]",
          "1996/03/01 00:01 [medline]",
          "1996/03/01 00:00 [entrez]"
     ],
     "AID": [
          "0091-3057(95)02058-6 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Pharmacol Biochem Behav. 1996 Mar;53(3):613-6.",
     "term": "hippocampus"
}